These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18703133)

  • 1. Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy.
    Carrico AW; Johnson MO; Morin SF; Remien RH; Riley ED; Hecht FM; Fuchs D
    Brain Behav Immun; 2008 Nov; 22(8):1257-62. PubMed ID: 18703133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy.
    Carrico AW; Johnson MO; Moskowitz JT; Neilands TB; Morin SF; Charlebois ED; Steward WT; Remien RH; Wong FL; Rotheram-Borus MJ; Lightfoot MA; Chesney MA;
    Psychosom Med; 2007 Nov; 69(8):785-92. PubMed ID: 17942835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users.
    Carrico AW; Johnson MO; Colfax GN; Moskowitz JT
    AIDS Behav; 2010 Aug; 14(4):769-77. PubMed ID: 19125321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
    Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulant use and HIV disease management among men in same-sex relationships.
    Carrico AW; Woolf-King SE; Neilands TB; Dilworth SE; Johnson MO
    Drug Alcohol Depend; 2014 Jun; 139():174-7. PubMed ID: 24726318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection.
    Carrico AW; Flentje A; Kober K; Lee S; Hunt P; Riley ED; Shoptaw S; Flowers E; Dilworth SE; Pahwa S; Aouizerat BE
    Brain Behav Immun; 2018 Jul; 71():108-115. PubMed ID: 29679637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Randomized Controlled Trial of a Syndemics Intervention with HIV-Positive, Cocaine-Using Women.
    Jemison D; Jackson S; Oni O; Cats-Baril D; Thomas-Smith S; Batchelder A; Rodriguez A; Dilworth SE; Metsch LR; Jones D; Feaster DJ; O'Cleirigh C; Ironson G; Carrico AW
    AIDS Behav; 2019 Sep; 23(9):2467-2476. PubMed ID: 31407212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    Carrico AW; Cherenack EM; Roach ME; Riley ED; Oni O; Dilworth SE; Shoptaw S; Hunt P; Roy S; Pallikkuth S; Pahwa S
    AIDS; 2018 Mar; 32(6):767-771. PubMed ID: 29369159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overamped: Stimulant Use and HIV Pathogenesis.
    Ross EJ; Williams RS; Viamonte M; Reynolds JM; Duncan DT; Paul RH; Carrico AW
    Curr HIV/AIDS Rep; 2023 Dec; 20(6):321-332. PubMed ID: 37971597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    Chahine A; Koru-Sengul T; Feaster DJ; Dilworth SE; Antoni MH; Klatt N; Roach ME; Pallikkuth S; Sharkey M; Salinas J; Stevenson M; Pahwa S; Fuchs D; Carrico AW
    J Acquir Immune Defic Syndr; 2021 Mar; 86(3):353-360. PubMed ID: 33165125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
    Carrico AW; Neilands TB; Dilworth SE; Evans JL; Gόmez W; Jain JP; Gandhi M; Shoptaw S; Horvath KJ; Coffin L; Discepola MV; Andrews R; Woods WJ; Feaster DJ; Moskowitz JT
    J Int AIDS Soc; 2019 Dec; 22(12):e25436. PubMed ID: 31860172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine.
    Lee JY; Glynn TR; Moskowitz JT; Fuchs D; Neilands TB; Dilworth SE; Feaster DJ; Rodriguez A; Carrico AW
    J Neurovirol; 2021 Feb; 27(1):178-182. PubMed ID: 33460015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
    J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and immune activation in patients with HIV-infection.
    Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
    Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.
    Yilmaz A; Price RW; Spudich S; Fuchs D; Hagberg L; Gisslén M
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):168-73. PubMed ID: 17971711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An autoregressive cross-lagged model unraveling co-occurring stimulant use and HIV: Results from a randomized controlled trial.
    Lee JY; Lee JE; Moskowitz JT; Feaster DJ; Neilands TB; Dilworth SE; Rodriguez A; Carrico AW
    Drug Alcohol Depend; 2021 Aug; 225():108752. PubMed ID: 34144507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
    Labhardt ND; Ringera I; Lejone TI; Klimkait T; Muhairwe J; Amstutz A; Glass TR
    JAMA; 2018 Mar; 319(11):1103-1112. PubMed ID: 29509839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy.
    Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H
    Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.